Home / JUBLPHARMA.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does JUBLPHARMA.NS make money? Does JUBLPHARMA.NS have pricing power? What's the Earnings Whisper? Will JUBLPHARMA.NS profit more as the business scales? What is JUBLPHARMA.NS's management track record? Is JUBLPHARMA.NS's current price justified?

Jubilant Pharmova Limited

₹938.6 -$119.50 (-11.29%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹938.2

Day Range

₹928.6₹954.9

Year Range

₹786.05₹1184.8

Market Cap

148.66B

AVG Volume

251.63K

Trailing/Forward PE

42.2/19.19

PEG ratio

-7.54

Dividend Yield

0.53%

Next Earnings Date

2026-10-30

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

JUBLPHARMA.NS Revenue (INR) by year
Period	Revenue (INR)
2026	82.8B
2025	72.34B
2024	67.03B
2023	62.82B
2022	61.3B
2021	76.19B
2020	83.32B
2019	91.11B
2018	75.18B
2017	58.61B

Net Income (INR) · A

JUBLPHARMA.NS Net Income (INR) by year
Period	Net Income (INR)
2026	3.98B
2025	8.39B
2024	771M
2023	-610M
2022	4.14B
2021	8.36B
2020	8.98B
2019	5.74B
2018	6.43B
2017	5.76B

Operating Income (INR) · A

JUBLPHARMA.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	13.19B
2025	23.56B
2024	20.64B
2023	19.85B
2022	25.4B
2021	30.58B
2020	28.76B
2019	35.59B
2018	30.12B
2017	0

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Jubilant Pharmova Limited

Video analysis: JUBLPHARMA.NS

News: JUBLPHARMA.NS

Similar companies